HIGHLIGHTS
- who: Zarrin Basharat and collaborators from the Research, International Center for Chemical and, University of, Buraydah, Saudi Arabia have published the Article: Inferring Therapeutic Targets in Candida albicans and Possible Inhibition through Natural Products: A Binding and Physiological Based Pharmacokinetics Snapshot, in the Journal: Life 2022, 1743 of /2022/
- what: The authors attempted to mine drug targets (n = 46) using a subtractive proteomic approach in this pathogenic yeast and screen natural products with inhibition potential against fructose-bisphosphate aldolase (FBA) of the C. albicans. This approach has become fundamental to pre-clinical screening of molecules . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.